|Immunogen||Synthetic peptide corresponding to 15 amino acids at the C-terminal of the Neuraminidase protein (Genbank Accession No. CAC95053).|
|Target/Specificity||Neuraminidase protein from the H5N1 strain of avian influenza (C-terminal).|
|Preservative||0.02% Sodium Azide|
|Format||Affinity Purified, Liquid|
|Storage||Store (up to 1 year) at 2-8°C.|
|Precautions||Rabbit Antibody to Influenza a H5N1 Neuraminidase (C-Terminal) is for research use only and not for use in diagnostic or therapeutic procedures.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The references listed below are for research purposes only:1. Thompson, W.W., et al., (2003), “Mortality associated with influenza and respiratory syncytial virus in the United States”, JAMA, 289: 179-186.2. Alexander, D.J., (2000), “A review of avian influenza. Proceedings of the European Society for Veterinary Virology (ESVV) Symposium on Influenza Viruses of Wild and Domestic Animals”, Vet. Microbiol., 74, 3-13.3. Shortridge, K.F., et al., (1998), “Characterization of avian H5N1 influenza viruses from poultry in Hong Kong”, Virol., 252: 331-342.4. Buxton Bridges, C., et al., (2000), “Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong”, J. Inf. Dis., 181: 344-348.5. Hulse, D.J., et al., (2004), “Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens”, J. Virol., 78: 9954-9964.
If you have any additional inquiries please email technical services at email@example.com.